Table of Contents

PerspectiveP:20-21

A comparison of the clinical and microbiological effects of syndromic pneumonia molecular testing in intensive care units
David Harrison*

DOI: 10.37532/ puljcmid.2022.5(3).20-21

• Full-Text
• PDF

PerspectiveP:22-23

SARS-CoV-2 virological and genomic studies in a favipiravir clinical trial cohort
Caroline Thomas*

DOI: 10.37532/puljcmid.2022.5(3).22-23

• Full-Text
• PDF

CommentaryP:24-25

Inflammatory bowel illness is associated with altered gut bacterial and metabolic profiles, as well as their interplay
Edward Wagner*

DOI: 10.37532/ puljcmid.2022.5(3).24-25

• Full-Text
• PDF

EditorialP:26-27

Streptomyces sp. UT4A49 metabolite analysis and biological control of tomato bacterial wilt disease
David Harrison*

DOI: 10.37532/ puljcmid.2022.5(3).26-27

• Abstract
• Full-Text
• PDF

OpinionP:28-29

From postmortem lung tissue, metagenomic detection of pathogenic microorganisms for pneumonia
Rebecca James*

DOI: 10.37532/ puljcmid.2022.5(3).28-29

• Abstract
• Full-Text
• PDF